Project Grant R01DK146265
- Federal Project Grant Award Summary Mayo Clinic received a $634,994 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, with completion targeted for January 31, 2030. The award supports fundamental biomedical research investigating the molecular mechanisms underlying sexually dimorphic traits of interstitial cells of Cajal...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Joslin Diabetes Center, Inc. a Project Grant totaling $150,583.00 (awarded September 15, 2025; completion date July 31, 2028) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research aimed at identifying the molecular drivers of insulin resistance and sex-specific alterations in glucose metabolism. The research...
- Federal Grant Award Summary Brigham & Women's Hospital Inc. received a $563,120 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with a completion date of August 31, 2027. The award funds mathematical modeling research focused on peripheral metabolic circadian rhythms and their implications for managing circadian disruption associated with shift work and jet lag. The...
- Federal Grant Award Summary The University of Colorado-Denver received a $625,508 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, with completion targeted for January 31, 2031. The award funds a randomized crossover trial investigating the cardiometabolic benefits of combined circadian rhythm advancement and sleep extension...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1.62M Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of Illinois, with performance commencing July 1, 2025, and concluding April 30, 2030. The research initiative, titled "MASLD Protection by STAT5-Regulated Transcription Factors," investigates the molecular mechanisms underlying...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Massachusetts General Hospital a $761,577 Project Grant on March 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct basic biomedical research examining the role of histone methylation in blood cell development. The research investigates how H3K4 methylation (H3K4me) and H3K27 methylation (H3K27me)—two critical...
- Federal Project Grant Award Summary Massachusetts General Hospital received a $133,328 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 20, 2025, with a completion date of September 19, 2026. The award funds basic biomedical research investigating the distinct roles of PPM1D (protein phosphatase 1D) and TP53 mutations in...
- Federal Grant Award Summary Boston Children's Hospital received a $168,543 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded May 1, 2026, with completion targeted for March 31, 2031. The grant supports biomedical research investigating the mechanisms of hypothalamic-pituitary-adrenal (HPA) axis suppression and recovery following long-term...
- Federal Project Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $834,911 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective April 1, 2026, with completion scheduled for January 31, 2031. The award supports basic biomedical research designed to map selective brain-to-gut communication pathways, specifically examining how...
- Federal Project Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $737,034 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025 through June 30, 2030. The research initiative aims to elucidate regulatory mechanisms governing coenzyme A (CoA) biosynthesis in response to metabolic signals, particularly...
Project Grant Award Summary Brigham & Women's Hospital Inc., operating under its Department of Faulkner Pathology, received a $894,808 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective April 1, 2026, through March 31, 2031, supports a five-year research initiative investigating sex differences in the adverse metabolic effects of shift work and circadian misalignment. The research addresses a critical gap in understanding how biological sex influences the metabolic consequences of night shift work, which disproportionately increases risks of obesity and diabetes in both male and female workforces. The project deliverables consist of controlled laboratory research examining sex-specific mechanisms through which circadian misalignment disrupts metabolic function. Primary research objectives include evaluating appetite-regulating hormones in women versus men, assessing glucose control impairment across sexes, and determining whether circadian misalignment increases homeostatic appetite in women while increasing hedonic appetite (cravings) in men. Secondary research will explore food-related neurocognitive control differences. Successful completion of this research is intended to generate evidence-based findings that support the development of sex-specific interventions and clinical strategies to mitigate health risks associated with shift work schedules.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $894.8k | 3/20/26 |